News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
838,270 Results
Type
Article (85989)
Company Profile (702)
Press Release (751579)
Section
Business (232450)
Career Advice (4118)
Deals (39690)
Drug Delivery (124)
Drug Development (90824)
Employer Resources (195)
FDA (18032)
Job Trends (17296)
News (395967)
Policy (39660)
Tag
Academia (2976)
Alliances (56690)
Alzheimer's disease (1413)
Approvals (17968)
Artificial intelligence (238)
Bankruptcy (398)
Best Places to Work (12631)
Biotechnology (481)
Breast cancer (235)
Cancer (1767)
Cardiovascular disease (146)
Career advice (3522)
CAR-T (134)
Cell therapy (379)
Clinical research (72488)
Collaboration (688)
Compensation (364)
COVID-19 (2832)
C-suite (163)
Data (1590)
Diabetes (228)
Diagnostics (6796)
Earnings (95192)
Employer resources (167)
Events (128131)
Executive appointments (578)
FDA (18927)
Funding (619)
Gene therapy (266)
GLP-1 (769)
Government (5080)
Healthcare (20817)
Infectious disease (2949)
Interviews (808)
IPO (17747)
Job creations (5183)
Job search strategy (2857)
Layoffs (516)
Legal (10077)
Lung cancer (267)
Manufacturing (264)
Medical device (14499)
Medtech (14504)
Mergers & acquisitions (22279)
Metabolic disorders (620)
Neuroscience (1859)
NextGen: Class of 2025 (7675)
Non-profit (5077)
Northern California (2038)
Obesity (350)
Opinion (257)
Patents (157)
People (64721)
Pharmaceutical (143)
Phase I (22355)
Phase II (31486)
Phase III (23709)
Pipeline (687)
Postmarket research (3551)
Preclinical (10036)
Radiopharmaceuticals (264)
Rare diseases (347)
Real estate (7379)
Regulatory (26329)
Research institute (2646)
Resumes & cover letters (649)
Southern California (1775)
Startups (4282)
United States (19152)
Vaccines (710)
Weight loss (265)
Date
Today (105)
Last 7 days (701)
Last 30 days (2793)
Last 365 days (37605)
2025 (3802)
2024 (38138)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1267)
Arizona (244)
Asia (49716)
Australia (8766)
California (4803)
Canada (1685)
China (404)
Colorado (221)
Connecticut (239)
Europe (113883)
Florida (683)
Georgia (171)
Illinois (533)
Indiana (275)
Maryland (783)
Massachusetts (3801)
Michigan (218)
Minnesota (355)
New Jersey (1364)
New York (1364)
North Carolina (964)
Northern California (2038)
Ohio (178)
Pennsylvania (1098)
South America (1649)
Southern California (1775)
Texas (716)
Utah (146)
Washington State (501)
There are 838,270 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Polycythemia Vera Market Size to Reach USD 79.0 Billion by 2035, Impelled by Advancements in Targeted Therapies.
February 11, 2025
·
11 min read
Drug Delivery
Explainer: The Thriving Shadow Market of GLP-1s for Weight Loss
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The situation is causing the FDA regulatory headaches and, more seriously, posing potential risks to the public.
February 11, 2025
·
5 min read
·
Ben Hargreaves
Press Releases
Nephrosclerosis Market Predicted to Grow at a Steady CAGR of 8.05% during 2025-2035, Impelled by Rising Occurrence of Hypertension and Diabetes
February 11, 2025
·
5 min read
Press Releases
Kiora Receives Approval to Initiate KLARITY, a Phase 2 Clinical Trial of KIO-104 for the Treatment of Retinal Macular Edema
February 11, 2025
·
5 min read
Press Releases
MustGrow Signs Exclusive Distribution Agreement with Adjuvants Plus Inc. for Biological Product Line
February 11, 2025
·
8 min read
Press Releases
Biophytis Unveils Its Outlook Strategies for 2025
February 11, 2025
·
4 min read
Press Releases
Chemiluminescence Immunoassay Market Size to Surpass 16.18 Bn by 2034
February 11, 2025
·
1 min read
Mergers & acquisitions
Novartis Bets Up to $3.1B to Buy Back Blood Thinner in Anthos Acquisition
Novartis is paying $925 million upfront to acquire Anthos Therapeutics, whose launch the pharma backed in February 2019.
February 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
TrialWire Platform AI Voice Screen to Boost Patient Engagement by 30% - Launched at Biotech Showcase 2025
February 11, 2025
·
1 min read
Mergers & acquisitions
Merck KGaA Courts Cancer Biotech SpringWorks for Potential Buyout
Following an initial report from
Reuters
, Merck KGaA confirmed that it is in talks with SpringWorks for a potential acquisition, though details of its offer have yet to be revealed.
February 11, 2025
·
2 min read
·
Tristan Manalac
1 of 83,827
Next
